Teva Loses Amgen Spying Suit Over Blood Drug Secrets

Law360, Los Angeles (April 30, 2013, 8:26 PM EDT) -- A California federal judge on Monday dismissed a suit alleging Amgen Inc. hired a “competitive intelligence” consulting firm to steal trade secrets about Teva Pharmaceuticals USA Inc.'s generic versions of blood drugs, finding Teva had no factual basis for its misappropriation claim.

U.S. District Judge Cormac J. Carney ruled that Teva's five other claims — including fraud, unfair competition and tortious interference with prospective business advantage — were preempted by the California Uniform Trade Secrets Act and Teva had not alleged sufficient facts to support its...
To view the full article, register now.